Translate page

iCMLf Forum 2018: Webstreams now available

iCMLf Forum 2018 Hughes 1Webstreams of the presentations from the iCMLf Forum for Physicians from Emerging Regions 2018 are now available to view. This year's Forum focused again on overcoming challenges treating CML featuring practical discussions with CML experts. CML experts gave the global perspective followed by local emerging regions perspectives from Ghana and Thailand and a discussion with the audience. 

Topics include:

  1. Perspectives on treating CML in pregnant patients 
    Professor Dragana Milojkovic (UK) and Dr Amma Benneh-Akwasi Kuma (Ghana) 
  2. Perspectives on treating CML in pediatric patients
    Professor Meinolf Suttorp (Germany) 
  3. Perspectives on adherence during TKI therapy
    Professor Saengsuree Jootar (Thailand)

Click on the presentations below to view the webstreams and see the slides.
(We are very grateful for the support of Brandcast media to produce these web streams) 




iCMLf Forum 2018 Miloskovic

Dragana Milojkovic
London, UK

Perspectives on managing CML during pregnancy:
A global perspective

Topics include; CML and pregnancy - how many patients are potentially affected?, CML diagnosed in pregnancy, unplanned pregnancy, Hammersmith study: parenting attemps in young female patients, suggested algorith for the management of pregnancy in CML. 





iCMLf Forum 2018 Benneh 1

Dr Amma Benneh-Akwasi-Kuma
Accra, Ghana

Perspectives on managing CML during pregnancy:
Perspectives from Ghana

Topics include; care of pregnant patients including once pregnant, conditions for start of hydroyurea and after delivery, preliminary data on pregnancies in CML at Korle-Bu Teaching Hospital, challenges of managing CML patients, conclusion.




iCMLf Forum 2018 SuttorpProfessor Meinolf Suttorp
Dresden, Germany

Perspectives on treating CML in pediatric patients:
A global perspective 

Topics include; off-target inhibition by TKIs licensed for minors, stopping TKI - hype or hope?, collecting data on pediatric CML, imatinib disrupts the growth hormone IGF-1 axis, changes in body mass index in pediatric patients with CML on imatinib, calcidiol blood levels in children with CML on imatinib, growth retardation on imatinib, impaired remodelling after bone fracture on imatinib, dental changes caused by imatinib, endocrine side effects besides axial growth impairment, drug interactions, conclusion.






iCMLf Forum 2018 JootarProfessor Saengsuree Jootar
Bangkok, Thailand

Perspectives on adherece during TKI therapy:
Perspectives from Thailand

Topics include; characteristics of Asian CML patients, CML in Ramathibodi Hospital, long-term adherence to imatinib is critical for achieving MR, practical strategies to improve adherence to TKI therapy, how to improve patients adherence, Thai CML Working Group, the importance of good communication.